Search by Drug Name or NDC

    NDC 00067-2021-24 Excedrin 250; 250; 65 mg/1; mg/1; mg/1 Details

    Excedrin 250; 250; 65 mg/1; mg/1; mg/1

    Excedrin is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.

    Product Information

    NDC 00067-2021
    Product ID 0067-2021_7cb14fb8-1195-4da3-b9d7-7375d26fa029
    Associated GPIs 64990003200350
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Excedrin
    Proprietary Name Suffix Extra Strength Geltabs
    Non-Proprietary Name Acetaminophen, Asprin, Caffeine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 250; 250; 65
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; ASPIRIN; CAFFEINE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part343
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-2021-24 (00067202124)

    NDC Package Code 0067-2021-24
    Billing NDC 00067202124
    Package 1 BOTTLE in 1 CARTON (0067-2021-24) / 24 TABLET, COATED in 1 BOTTLE
    Marketing Start Date 2011-09-13
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 11a8439b-0159-4351-b0f5-fe7fad6a33c0 Details

    Revised: 12/2020